Agios Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 30/07/2026 | Mar 2026Filed 30/07/2026 | Sep 2025Filed 30/10/2025 | Jun 2025Filed 30/07/2026 | Mar 2025Filed 30/07/2026 | Sep 2024Filed 30/10/2025 | Jun 2024Filed 30/10/2025 | Mar 2024Filed 30/10/2025 |
|---|---|---|---|---|---|---|---|---|
| $45 | $21 | $13 | $12 | $8.7 | $9 | $8.6 | $8.2 | |
| −$101 | −$99 | −$103 | −$112 | −$89 | $948 | −$96 | −$82 | |
| −$1.69 | −$1.69 | −$1.78 | −$1.93 | −$1.55 | $16.22 | −$1.69 | −$1.45 | |
| 59 | 59 | 58 | 58 | 57 | 58 | 57 | 56 |
Trend